Processa Pharmaceuticals Competitors or Alternatives
Processa Pharmaceuticals's top competitors include GlycoMimetics, Galecto and Inovio.
Processa Pharmaceuticals VS GlycoMimetics
GlycoMimetics is one of Processa Pharmaceuticals's top competitors. GlycoMimetics was founded in 2003 in Rockville, Maryland. Like Processa Pharmaceuticals, GlycoMimetics also operates in the Biotechnology industry. GlycoMimetics generates $103.4K less revenue than Processa Pharmaceuticals.
Processa Pharmaceuticals VS Galecto
Galecto is a top competitor of Processa Pharmaceuticals. Galecto was founded in 2011, and is headquartered in Boston, Massachusetts. Like Processa Pharmaceuticals, Galecto also competes in the Pharmaceuticals field. Galecto generates $ less revenue vs. Processa Pharmaceuticals.
Processa Pharmaceuticals VS Inovio
Inovio is seen as one of Processa Pharmaceuticals's top competitors. Inovio is headquartered in Plymouth Meeting, Pennsylvania, and was founded in 1979. Like Processa Pharmaceuticals, Inovio also operates in the Biotechnology field. Inovio generates 160% the revenue of Processa Pharmaceuticals.
Looking for similar companies to Processa Pharmaceuticals?
Similar Companies
Companies in Hanover with employees in 1-25 range
See 106 companies
Pharmaceuticals companies in MarylandSee 174 companies
Companies in Hanover with revenue in $100K-5.0M rangeSee 285 companies
Biotechnology companies in MarylandSee 395 companies
Pharmaceuticals & Biotechnology companies in MarylandSee 524 companies
Pharmaceuticals companies with employees in 1-25 rangeSee 2,170 companies
Pharmaceuticals companies with revenue in $100K-5.0M rangeSee 2,193 companies
Biotechnology companies with employees in 1-25 rangeSee 3,313 companies
Biotechnology companies with revenue in $100K-5.0M rangeSee 4,526 companies
Trending News for Processa Pharmaceuticals and Processa Pharmaceuticals's Competitors
CRF acquired Spark Therapeutics, Inc.'s SPK-7001 CHM gene therapy assets and is analyzing long-term data to identify key clinical measures for developm...
Enhertu (trastuzumab deruxtecan) has been approved in China for the treatment of adult patients with locally advanced or metastatic HER2 positive (IHC ...
Vas Narasimhan, CEO of Novartis AG (NYSE:NVS), said the Swiss drugmaker's expanding U.S. manufacturing footprint and a December agreement with the U.S....
Coherent Market Insights has released a report titled "Fc Fusion Protein Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2...
AbelZeta Pharma said AstraZeneca has agreed to acquire AbelZeta's remaining 50% stake in the China development and commercialization rights for C-CAR03...
Coherent Market Insights has released a report titled "Fc Fusion Protein Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2...
MSN Laboratories Pvt. Ltd. can't reopen disputes resolved in earlier litigation over the scope, validity, and infringement of a patent for Novartis AG'...
Ontario is reportedly the first province to fund Tagrisso for patients with non-small cell lung cancer, and Calquence for patients with previously untr...
Frequently Asked Questions about Processa Pharmaceuticals
Who are Processa Pharmaceuticals's top competitors?
Processa Pharmaceuticals's top 3 competitors are GlycoMimetics, Galecto, Inovio.Who is similar to Processa Pharmaceuticals?
GlycoMimetics is the most similar to Processa Pharmaceuticals. Galecto and Inovio are also similar to Processa Pharmaceuticals.
Are Processa Pharmaceuticals and GlycoMimetics competitors?
Yes, GlycoMimetics is one of Processa Pharmaceuticals’s top competitors.